Avanzanite Bioscience is a startup. 1 investor tracked.
Avanzanite Bioscience is a startup founded in 2022 based in the Netherlands. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Avanzanite Bioscience is a commercial-stage European specialty pharmaceutical company focused on rare diseases, offering end-to-end commercialization and distribution partnerships with research-based biopharmaceutical originators to unlock the full value of their orphan medicines in European markets.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.